Should I get my hormones tested if my periods or mood have changed?

Yes, symptom-driven hormone testing is a different situation from predictive testing, and it is often worth doing. New irregular cycles, heavy bleeding, hair changes, or mood that tracks your cycle can point to PCOS, thyroid disease, perimenopause, or PMDD, and each has its own workup with labs chosen for the question. That is testing with a hypothesis, which is where labs do their best work.

Should I get my hormones tested if my periods or mood have changed?

Yes, symptom-driven hormone testing is a different situation from predictive testing, and it is often worth doing. New irregular cycles, heavy bleeding, hair changes, or mood that tracks your cycle can point to PCOS, thyroid disease, perimenopause, or PMDD, and each has its own workup with labs chosen for the question. That is testing with a hypothesis, which is where labs do their best work.

Hormone Testing Before Birth Control: What Helps, What Doesn't | Philadelphia

TL;DR30-second take

No blood or genetic test can yet predict which birth control will suit you. What testing can do is catch safety issues: clotting risk, blood pressure, and migraine with aura, which rules out estrogen-containing methods. The reliable path to the right contraception is a full history, an honest read of past reactions, and a physician who follows you and adjusts. Fishtown Medicine prescribes and manages birth control as part of whole-person care.

TL;DR: New services sell hormone and DNA tests that promise to match you to the right birth control. The honest science: no test can yet predict which method will make you feel good. Testing does matter for safety, things like clotting risk and blood pressure, and 1 rule is firm: migraine with aura means no estrogen-containing birth control. What finds your fit is your own history (what each method did to your mood, skin, bleeding, and sex drive) plus a doctor who keeps adjusting with you instead of guessing once. If a method changed how you feel, believe your own experience, and bring it to someone who will treat it as data.

If you are researching test-first birth control, I can usually guess the road behind you. A pill at 16 for cramps or skin. A different one at 22 when the first flattened your mood. Maybe an IUD (intrauterine device) that a clinician said would be a pinch and was not. Each change came with the same send-off: give it 3 months and see how it goes.

So when a service offers to test your hormones and your genes and compute the method that fits your biology, it sounds like the thing you have been asking for all along: evidence instead of trial and error. The impulse is right, and parts of the testing are useful. But you deserve a straight answer about which parts, because the gap between what these panels measure and what they can predict is wide.

Can a hormone test predict the right birth control?

Not yet, and I wish the answer were different. A baseline hormone panel, estradiol, progesterone, FSH, testosterone, tells us where your cycle stands the week of the draw. What it cannot do is forecast how your brain and body will respond to a synthetic progestin layered on top. Two women with near-identical baseline labs can have opposite experiences on the same pill, and the response differences live mostly in receptor sensitivity and brain chemistry that no commercial panel reads.

The genetic side is younger still. Research into variants that shape hormone metabolism and side-effect risk is serious science and worth watching, and a family-linked clotting variant matters when the history points there. But no genetic result is validated today to select a contraceptive method, and a report implying otherwise is ahead of its evidence.

What your money buys from a test-first service, in practice, is a data snapshot plus a one-time consult. The snapshot is not worthless. It is simply not the instrument that finds your method.

Which tests and screenings matter for birth control safety?

Safety screening is a different story, and here medicine has firm, evidence-backed rules. Before anyone starts an estrogen-containing method (combined pills, the patch, the ring), 4 things need checking, and none of them requires a subscription:

Migraine with aura. Visual changes, numbness, or speech changes before the headache. The CDC's medical eligibility criteria classify combined hormonal contraception as an unacceptable risk here, because estrogen plus aura multiplies stroke risk. Progestin-only methods and IUDs remain fully open. A surprising number of women carrying this diagnosis were never asked.
Blood pressure. A proper reading, seated and rested. Uncontrolled hypertension moves estrogen methods off the table.
Clot history. Yours and your family's. A parent or sibling with an unprovoked blood clot changes the calculation, and is the situation where targeted clotting-factor testing (like Factor V Leiden) earns its place. Testing everyone is not recommended; testing the right history is.
Smoking after 35. Combined with estrogen, the clot risk stacks.

And 1 more piece of screening that belongs on the list even though no kit sells it: your mental health history. Large registry data links hormonal contraception with higher rates of new antidepressant use, most visibly in teenagers, and if your mood dropped on a method before, that pattern is a clinical data point to design around, never a coincidence to push through.

What does finding the right method look like?

The reliable instrument is a structured history plus follow-up, which is slower than a lab panel and works better. When a patient and I work through contraception, the map looks like this: every method you have tried and what each did to mood, bleeding, skin, weight, headaches, and sex drive; your cycle off hormones; your migraine and clot screening; what you want the method to do beyond preventing pregnancy (calm PMDD, control bleeding, clear skin) and what you refuse to trade for it.

That last part matters more than any test. A method that protects your pregnancy plans while dimming your libido or flattening your mood is not a success, and you should not need to argue for that. Sexual health is health. The follow-up is where the fit gets found: a check-in at 6 to 8 weeks, a structured comparison against your baseline, and a low threshold for changing course, because with a dozen meaningfully different options (4 generations of progestins, 3 doses of estrogen, hormonal and copper IUDs, the implant, the shot), the search is navigable when someone stays in it with you.

At Fishtown Medicine this is primary care, in every sense. I prescribe and manage contraception alongside everything it touches: your mood, your skin, your PCOS if that diagnosis is in the mix, your iron if bleeding has been heavy, your sex drive, your plans. Visits run 30 to 90 minutes, follow-ups happen by text instead of another appointment you have to fight for, and the person adjusting your method is the same person who knows the rest of your chart. If you have a hormone panel from a testing service, bring it. It joins the story; it does not replace it.

Actionable Steps to Find Your Fit

Bring evidence a test cannot generate.

Write your method history. Each birth control you have tried, roughly when, and what changed on it: mood, bleeding, skin, headaches, sex drive. 10 minutes, and it outperforms any panel.
Screen yourself for aura. Before headaches, have you ever had visual sparkles, blind spots, numbness, or trouble finding words? Bring the answer; it redraws the option map.
Collect the family clot history. Blood clots in legs or lungs in parents or siblings, and any clots around pregnancy or surgery. This decides whether clotting-factor testing is worth running.
Name what you want the method to do. Pregnancy prevention plus what: lighter periods, calmer PMDD, clearer skin, nothing daily. Tell Dr. Ash what's going on, and the search starts from your goals instead of a default.

Key Takeaways

No hormone panel or consumer genetic test can predict which birth control will suit you; response lives in receptor and brain chemistry the tests cannot read.
Safety screening is where testing matters: blood pressure, clot history with targeted testing when indicated, and migraine-with-aura screening, which rules out estrogen-containing methods.
Mood and libido effects of hormonal contraception are documented and individual. Your own history on each method is the most predictive data that exists.
The reliable path is a structured history, a purposeful method choice, and a 6-to-8-week follow-up with a prescriber willing to change course.
Fishtown Medicine manages contraception inside whole-person primary care, where your mood, skin, cycles, and sex life are part of the same conversation.

PCOS Care in Philadelphia - when cycles, skin, and metabolism point to a diagnosis.
Hormone Optimization - the broader hormone practice.
The Hormones Library - guides on testing, cycles, and treatment.
Perimenopause Care - when the contraception conversation changes shape.

Scientific References

Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recommendations and Reports. 2024;73(RR-4):1-126.
Skovlund CW, Mørch LS, Kessing LV, Lidegaard Ø. Association of Hormonal Contraception With Depression. JAMA Psychiatry. 2016;73(11):1154-1162.
de Bastos M, Stegeman BH, Rosendaal FR, et al. Combined oral contraceptives: venous thrombosis. Cochrane Database of Systematic Reviews. 2014;(3):CD010813.
Lopez LM, Kaptein AA, Helmerhorst FM. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database of Systematic Reviews. 2012;(2):CD006586.

Fishtown Medicine | Hormones

2418 E York St, Philadelphia, PA 19125(267) 360-7927 hello@fishtownmedicine.comHSA/FSA Eligible

Start your intake

Frequently Asked Questions

Common Questions

No blood test can currently predict which birth control method will suit you. Baseline hormone levels describe your cycle at one moment, and the side effects that drive most switching, mood changes, libido loss, bleeding patterns, come from how your receptors and brain respond to a synthetic hormone, which the panel cannot measure. Testing earns its place in safety screening instead: blood pressure always, and clotting-factor tests when personal or family history suggests them.

DNA testing for contraceptive selection is early-stage science sold ahead of its evidence. Research into genetic variants that shape hormone response is underway and worth watching, but no genetic result is validated today to choose a method. The exception with clinical standing is targeted clotting-factor testing, such as Factor V Leiden, when your personal or family clot history makes it relevant, and that test is best ordered through a physician who will act on the result.

Migraine with aura, meaning visual changes, numbness, or speech disturbance before the headache, marks a higher baseline stroke risk, and estrogen-containing contraception raises that risk further. The CDC's medical eligibility criteria rate combined hormonal methods an unacceptable risk with aura. Every progestin-only option, including the mini-pill, implant, shot, and hormonal IUD, plus the copper IUD, remains available, so the diagnosis narrows the list without emptying it.

Yes, for some women, and both effects are documented rather than imagined. A large Danish registry study found higher rates of first antidepressant use after starting hormonal contraception, with the strongest signal in adolescents, and libido changes are among the most commonly reported reasons for switching methods. Neither happens to most users, which is why your individual history on each method is the data that matters. A method that flattens your mood or your sex life is a method worth changing.

Yes. Fishtown Medicine prescribes contraception, including combined and progestin-only pills, and coordinates IUD or implant placement when a procedure is the right choice, then manages the follow-up: a structured check-in at 6 to 8 weeks, adjustments by secure text without a new appointment for every question, and attention to everything the method touches, from mood to bleeding to skin. Family planning conversations, including when to stop contraception and what to expect after, are part of the same care.

Deep-Dive Questions

Because the drug is only half the equation. Progestins differ across 4 generations in how they touch androgen, estrogen, and mineralocorticoid receptors, and women differ in receptor density, neurosteroid sensitivity, and baseline mood architecture. The same molecule can clear one woman's skin and drop another's mood within weeks. This is why a static hormone snapshot predicts so little, and why N-of-1 evidence, your own documented response to each method, remains the best guide medicine has.

Use it for what it measures, and refuse the overreach. A baseline hormone panel is a legitimate data point, and any service that screens blood pressure and clot history is doing the safety work that matters. Where to stop believing: any claim that the panel or a genetic score has computed your best method. Take the data, then put it inside a longitudinal relationship where someone tracks what the chosen method does to you and iterates. Data plus follow-through is the whole trick; the kit sells only the first half.

PMDD (premenstrual dysphoric disorder) moves contraception from pregnancy prevention toward treatment, and it raises the cost of getting the progestin wrong. Continuous or extended-cycle dosing of specific formulations can help in a measurable way, drospirenone-containing pills carry the best evidence, while the wrong progestin can deepen the low weeks. This is a place where cycle tracking before and after a change, and a prescriber who weighs the mood data as heavily as the bleeding data, decide the outcome.

A structured comparison against baseline: mood, bleeding pattern, headaches, skin, sex drive, blood pressure again if the method contains estrogen. Side effects that are settling get distinguished from ones that are declaring themselves, and a change of course gets made without ceremony when the trade is not worth it. The visit takes 20 minutes. Its absence is how women end up 8 years into a method that never fit, assuming this is just how they feel now.

Ready when you are